mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.7 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |